Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 13, 2014Expert Review of Clinical ImmunologyOpen Access

Immunological basis in the pathogenesis and treatment of bladder cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

DTDavid B. ThompsonLSLarry E. SirefMFMichael Feloney

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Thompson et al. (2014) studied this question.

synapsesocial.com/papers/6a6f1a9c5671bbf00bc28a07https://doi.org/10.1586/1744666x.2015.983082
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Innate Transcriptional Networks Activated in Bladder in Response to Uropathogenic <i>Escherichia coli</i> Drive Diverse Biological Pathways and Rapid Synthesis of IL-10 for Defense against Bacterial Urinary Tract Infection2011 · 93 citations
  2. 2Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder Cancer2012 · 134 citations
  3. 3Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer2001 · 1,340 citations
  4. 4Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes2005 · 354 citations
  5. 5Biology and Management of Bladder Cancer1990 · 437 citations